Navigation Links
Dietary phytonutrients – Secret for the good food to taste ba

Phytonutrients have been associated with cancer prevention and other health benefits. They are trace chemicals and taste bitter, acid or astringent. If phytonutrients have to be consumed then demands of good taste and good health may be wholly incompatible.

The bitter phytonutrients protect the plant against being eaten by harmful herbivores. The plants which contains phyto nutrients are Sprouts, grapefruit, cabbage, kale, mustard seeds, arugula, spinach, dark chocolates and it is understood that small amount of phenol, flavanoids,isoflavones are needed to stay healthy. But the food manufacturers remove phytonutrients by debittering process, as the humans have the tendency to avoid bitter food as spoiled or poisonous in nature.

The solution to overcome the bitterness is to follow Mediterranean cuisine or to prepare it with oil like in American diet.
'"/>




Page: 1

Related medicine news :

1. New Dietary Approach To Manage Kidney Stones
2. Dietary advice for diabetes
3. Dietary cure for fighting Helicobacter pylori
4. Dietary Changes Could Reduce The Risk for Stroke
5. Tackling Prostate Cancer With A New Dietary Supplement
6. Teenagers Using Hormones And Dietary Supplements To Good Physique
7. Dietary supplementation of Folic Acid Requires Critical Evaluation
8. Adding Sorghum Compounds To Dietary Supplements May Help Lower Cholesterol
9. Dietary pattern of Soy consumption among women at risk for breast cancer
10. Dietary intake of Vitamin E by type 2 diabetics for prevention of atherosclerosis
11. Dietary intake of Vitamin E by type 2 diabetics for prevention of atherosclerosis
Post Your Comments:
(Date:5/17/2008)...t report could not establish safe-limit price as g..., May 17 (HealthDay News) -- Those inexpensive ear...y be good for your wallet but bad for your ears an... earrings sold for less than $50 by local San Fran... cause dermatitis on the earlobes and repeated exp...
(Date:5/16/2008)NEW YORK, May 16 /PRNewswire/ -- There,s more to a healthy mouth than,flashing a set of pearly whites. Here,s the scoop on America,s oral care,habits - and what it means for our overall health.,
(Date:5/16/2008)... Contract Covers More than 500 Workers, WASHINGT...0 paramedics,and emergency medical technicians in ...gton area have ratified their first-ever contract ...ese workers are now covered by a,strong contract t...ent,future," said Teamsters General President Jim ...
(Date:5/16/2008)...Small fibroids located just beneath the lining of ... the endometrial cavity after uterine artery embol...ations, according to a new study. , The study i...t an MRI examination before and after UAE. The stu...e, 33% migrated to the endometrial cavity after UA...
Breaking Medicine News(10 mins):Health News:Cheaper Earrings More Likely to Contain Nickel 2Health News:Cheaper Earrings More Likely to Contain Nickel 3
... the AMA Rural Reference Group (AMARRG), Dr David ...y Transport Minister, Warren Truss, //of enhanceme...) was a welcome piece of rare good news for rural ...igned to attract GPs to work in country areas and ...
...xperts at University of Iowa are taking efforts to...cribed only when really needed.// Salmeterol is a...on with a corticosteroid, which is inhaled. The us...iorate the asthma for a few people with that condi...
...ers have uncovered important information about how... a critical step in DNA mutation that has eluded r...rs in the August edition of the Journal of the Ame... Institute of Technology have reported uncovering ...
...e about three severe, potentially fatal genetic di...that they can rupture in pregnancy and labor or ev...a blockers, curbing exercise, proactive blood vess...be helpful, but their usefulness varies according ...
Other Medicine News:Health News:RMIF Boost a Boon for Rural Health 2Health News:Salmeterol - to be used in combination & only when required 2Health News:Salmeterol - to be used in combination & only when required 3Health News:Elusive Step In DNA Mutation Uncovered By Researchers 2Health News:Elusive Step In DNA Mutation Uncovered By Researchers 3Health News:Elusive Step In DNA Mutation Uncovered By Researchers 4Health News:Scientists Review Loeys-Dietz Syndrome in the Largest Ever Study to date 2Health News:Scientists Review Loeys-Dietz Syndrome in the Largest Ever Study to date 3
(Date:5/15/2008)... Patients with breast or,colorectal cancer, two of...er treatment advances with Avastin(R) (bevacizumab...a that is being presented at the 44th,American Soc... Chicago at,the end of May. Around 30,000 medical ...er event for cancer therapy worldwide., The Roche...
(Date:5/15/2008)...tate, Colorectal and Ovarian ...ent on Sun., June 1 with Oncology Experts -, SOUT...all/ -- Poniard,Pharmaceuticals, Inc. (Nasdaq: PA...ogy, today announced that the Company will present... various tumor types and combinations, at,poster s...
(Date:5/15/2008)...cts depth and breadth of, collaboration with inve... diverse forms of cancer -... the leading IV, bisphosphonate, on relapse rate o... oral sessions to feature RAD001, first oral once-...st results of RECORD-1 study in renal cell ...
(Date:5/15/2008)...tCall/ -- Sanofi-aventis,(EURONEXT: SAN and NYSE: ...rk ATHENA study showed Multaq(R) (dronedarone), a ...th atrial fibrillation or atrial flutter,decrease...eath from any,cause by a statistically significant...point. The ATHENA results will be presented at the...
Breaking Medicine Technology:New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 2New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 3New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 4New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 5New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 6Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 2Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 3Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 4Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 5Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 2Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 3Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 4Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 5Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 6Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 7Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 8Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 9Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 10Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 2Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 3Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 4Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 5Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 6Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 7Coalition America Renews Relationship with Musketeer to Offer Streamlined Claims Repricing and Adjudication Solution for Benefit Administrators 1971 1Coalition America Renews Relationship with Musketeer to Offer Streamlined Claims Repricing and Adjudication Solution for Benefit Administrators 1971 2Race Against Pain Coming to California 1968 1Race Against Pain Coming to California 1968 2Race Against Pain Coming to California 1968 3Portico Systems Wins Three Awards in 30 Days 1965 1Portico Systems Wins Three Awards in 30 Days 1965 2Signalife Receives Another 243 3 Million Sales Orders 813 1Signalife Receives Another 243 3 Million Sales Orders 813 2
...nd VANCOUVER, April 26, 2007,/PRNewswire-FirstCall...cialty pharmaceutical and medical device company, ... pivotal trial examining the,Vascular Wrap(TM) Pac... presented today at a scientific forum in Europe. ...y of the Vascular,Wrap(TM) for use in arterial byp...
...pril 26, 2007 /PRNewswire-FirstCall/ --,Australian...nnounced preliminary results from its randomised P... colorectal cancer, where,Alchemia,s drug HyCAMP(T...to be a cornerstone drug for the treatment of colo...a preliminary stage of,the analysis in accordance ...
Other Medicine Technology:Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 2Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 3Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 4Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 5Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 6Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 7Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 2Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 3Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 4Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 5Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 6Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 7
For use with 8 channel pipets.
...sign, manually adjustable dispensing head, and dis...e brings unparalleled flexibility and cost-efficie...t instrument of its kind to offer fast dispensing ...,000L). It also offers the added benefit of being ...
...atented non-contact dispensing technique that coup...valve and stage stepper motor. synQUAD dispenses a...lides, plates, or membranes. At 100 nL dispense vo...less than 10%. An 8-channel synQUAD system dispens...
The WP1000S is a shortened base version of the WellPro that is shortened 5 inches to facilitate fitting into smaller biohazard hoods.
Medicine Products: